NIBSC21/170 1st International Standard 2022 for the in vitro bioactivities of Cetuximab 21/170
产品详情如下，更多产品详情，请咨询客服，供实验室使用！
| Product description | 1st International Standard 2022 for the in vitro bioactivities of Cetuximab |
| Product number | 21/170 NIBSC21/170 |
| Category | Biotherapeutics Monoclonal Antibodies |
| Keywords | Monoclonal antibodies Bioassays In vitro bioactivity |
| Type of standard | International Standard |
| Instructions for Use | 21-170.pdf Instructions for Use |
| Minimum quantity | 1 |
部分相关产品如下，更多相关产品的详细信息，请咨询客服，供实验室使用！
Related Products
98/774 Influenza Antigen B/Shangdong/7/97 流感抗原B/山东/97
99/586 Influenza Antigen B/Yamanashi/166/98 流感抗原B/山梨县/166/98
99/828 Influenza Antigen B/Yamanashi/166/98 流感抗原B/山梨县/166/98
12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived) 流感抗原B/威斯康辛州/2010年1月（细胞衍生）
87/774 Influenza Antigen B/Victoria/2/87 流感抗原B/维多利亚/2/87